IAN
TMO icon

Integrated Advisors Network’s Thermo Fisher Scientific TMO Stock Holding History

Integrated Advisors Network’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.08M Sell
2,163
-59
-3% -$28.3K 0.05% 306
2026
Q1 		$1.09M Buy
2,222
+52
+2% +$28.2K 0.06% 296
2025
Q4 		$1.26M Buy
2,170
+458
+27% +$259K 0.06% 306
2025
Q3 		$831K Buy
1,712
+189
+12% +$88K 0.03% 400
2025
Q2 		$618K Buy
1,523
+75
+5% +$31.4K 0.03% 450
2025
Q1 		$721K Sell
1,448
-56
-4% -$30.3K 0.04% 376
2024
Q4 		$782K Sell
1,504
-128
-8% -$70.4K 0.04% 350
2024
Q3 		$1.01M Sell
1,632
-274
-14% -$162K 0.05% 313
2024
Q2 		$1.05M Buy
1,906
+179
+10% +$103K 0.05% 300
2024
Q1 		$1M Buy
1,727
+206
+14% +$116K 0.05% 311
2023
Q4 		$807K Sell
1,521
-186
-11% -$90K 0.05% 323
2023
Q3 		$864K Sell
1,707
-248
-13% -$132K 0.05% 307
2023
Q2 		$1.02M Sell
1,955
-107
-5% -$57.7K 0.06% 284
2023
Q1 		$1.19M Sell
2,062
-111
-5% -$62.6K 0.07% 259
2022
Q4 		$1.2M Sell
2,173
-376
-15% -$199K 0.08% 256
2022
Q3 		$1.29M Sell
2,549
-349
-12% -$195K 0.09% 236
2022
Q2 		$1.57M Sell
2,898
-431
-13% -$237K 0.1% 216
2022
Q1 		$1.97M Sell
3,329
-269
-7% -$155K 0.12% 194
2021
Q4 		$2.4M Buy
3,598
+78
+2% +$48.7K 0.14% 164
2021
Q3 		$2.01M Buy
3,520
+135
+4% +$74.1K 0.13% 171
2021
Q2 		$1.71M Buy
3,385
+120
+4% +$56.6K 0.13% 170
2021
Q1 		$1.49M Buy
3,265
+14
+0.4% +$6.68K 0.14% 162
2020
Q4 		$1.51M Sell
3,251
-69
-2% -$32.4K 0.17% 149
2020
Q3 		$1.47M Buy
3,320
+67
+2% +$27.7K 0.19% 134
2020
Q2 		$1.18M Buy
3,253
+579
+22% +$194K 0.14% 170
2020
Q1 		$758K Sell
2,674
-1,675
-39% -$528K 0.15% 153
2019
Q4 		$1.41M Buy
+4,349
New +$1.32M 0.19% 158

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Integrated Advisors Network's TMO Position: Q2 2026 in Review

Integrated Advisors Network reduced its Thermo Fisher Scientific (TMO) stake by 2.7% in Q2 2026, selling an estimated $28.3K and leaving 2,163 shares worth $1.08M. The position accounts for 0.05% of the portfolio, ranked #306.

Integrated Advisors Network first reported a position in TMO in Q4 2019 and has held it in 27 quarters since. The position peaked at $2.4M in Q4 2021. 2,624 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Integrated Advisors Network held 2,163 shares of Thermo Fisher Scientific worth $1.08M as of Q2 2026.
  • Integrated Advisors Network sold 59 Thermo Fisher Scientific shares in Q2 2026, an estimated $28.3K.
  • Thermo Fisher Scientific made up 0.05% of Integrated Advisors Network's portfolio in Q2 2026, its #306 holding.
  • Integrated Advisors Network first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 27 quarters since.
  • Integrated Advisors Network's Thermo Fisher Scientific position peaked at $2.4M in Q4 2021.
  • 2,624 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Integrated Advisors Network's 13F filing for Q2 2026, filed 11 Aug 2026.